...Benedict Breitling; Claudia Bartels; Claudia Lange; Caroline Bouter; Hannah Sönne Falk; Jens Wiltfang; David Zilles-Wegner; Matthias Besse Introduction: Diagnosis of frontotemporal dementia (FTD) remains difficult even in the presence of core clinical and imaging features. Furthermore, disease...

... to a high risk for cognitive impairment and dementia. The present study aimed to measure plasma Aβ peptides (Aβ40, Aβ42) and the Aβ40/Aβ42 ratio in a sample of drug-resistant bipolar depressed patients, as well as to explore the possible correlation between biological parameters and clinical changes along...

... and long-term prognosis. We examined the effects of cerebrovascular changes on the course of geriatric depressive symptoms, dementia rates, and mortality over a follow-up period of approximately 10 years. Method: Participants were 84 patients with major depression (age of onset over 50 years); patients...

...Giovanni Murialdo; Francesco Zerbi; Ugo Filippi; Pietro Tosca; Stefano Fonzi; Enrica Di Paolo; Patrizia Costelli; Savino Porro; Alessandro Polleri; Faustino Savoldi An impairment of cholinergic and somatostatinergic neurotransmission have been reported in dementia. Both acetylcholine...

... (CSF) of patients with dementia were performed. Levels of UTIRS in the dementia group were significantly (p < 0.01) lower than those in dementia-free subjects. In addition, lower levels of UTIRS were registered in subjects afflicted with a higher severity of dementia. However, the levels of αlMIRS...

... as assessed by positron emission tomography (PET) with 18 F-2-deoxyglucose (FDG) were obtained on 36 patients with mild to moderate senile dementia of the Alzheimer type and 17 age- and sex-matched normal control subjects. Subjects performed a verbal memory task during uptake of FDG. There were significant...

... (for results of treatment phase see part II, in preparation). The pretreatment state was evaluated twice using quantitative-topological EEG (qEEG) and psychopathological rating scales. There is a significant correlation between total score values of nearly all dementia-specific neuropsychological rating scales...

..., instructions or products referred to in the content or advertisements. Dementia Treatment Cyclandelate Rating scales EEG Psychometry Neuropsydiobiology P h arm aco psychiatry Main Editor: B. Saletu (Vienna) Original Paper Neuropsychobiology 1997:35:132-142 R. Schellenberga A. Todorovaa W...

...L.A. Riquelme; B.S. Zanuto; M.G. Murer; R.J. Lombardo Previous studies from different laboratories have suggested that qEEG could be useful for distinguishing dementia from normality. Our aims were: (1) to study the ability of qEEG to distinguish dementia among different pathological conditions...

...Ralf Ihl; Thomas Dierks; Lutz Froelich; Eva-Maria Martin; Konrad Maurer Studies on EEG data in dementia of the Alzheimer type have mainly investigated parameters in the frequency domain. However, the EEG also reflects the momentary functional state of the brain. The EEG can be partitioned...

... been described in primary dementia. In this study we have evaluated the effects of acetylcholines-terase inhibition by pyridostigmine on growth hormone (GH), adrenocorticotropic hormone (ACTH) and cortisol secretion and on their responses to GH-releasing hormone (GHRH) and corticotropin-releasing...

...Alberto Primavera; Paolo Novello The relationship between depression and dementia in Parkinson’s disease (PD) has rarely been explored. Using a quantitative EEG (qEEG) parameter, we studied four groups of subjects: PD, demented Alzheimer’s type and major depressed patients and normal controls...

...Walter G. Sannita; Lino Maggi; Guido Rosadini There has been clinical and experimental evidence that cholinergic compounds and precursors of choline are potentially useful in the treatment of dementia. Anticholinergic compounds have also been proposed as a possible acute model for pharmaco-EEG...

...L.C. Morey; T.A. Ban; G. Cassano; V. Santini; G.F Placidi; A. Modafferi; A. Postiglione In a multicenter clinical trial, two dosages of glycosaminoglycan polysulfate were compared in patients with primary degenerative dementia and multi-infarct dementia. Psychopathologic symptoms were assessed...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Alzheimer’s disease Dementia Serotonin (5-HT) Aggressive behaviour Tryptophan Pharmacopsychiatry Neuropsychobiology 15: 133-142(1986) Alzheimer s Disease and Serotonin...

... aetiological factor in aging and dementia are described. 14 2 2008 © 1976 S. Karger AG, Basel 1976 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means...

... be observed with respect to cognitive performance (p = 0.02) and social functioning (p = 0.001) regardless of the stage of dementia, whether mild or moderately severe. However, the relative changes from baseline measured at endpoint depended heavily on the severity at baseline. Improvement was observed...

..., instructions or products referred to in the content or advertisements. EEG Dementia Alzheimer’s disease Therapy Acetylcholinesterase inhibitor Rivastigmine Pharmacoelectroencephalography Original Paper Neuropsychobio0ogy 2001;43:273 276 Short-Term Rivastigmine Treatment Reduces EEG Slow-Wave...

... leucodystrophy (MLD) is a disease caused by deficiency of the enzyme ASA. Clinically, adult MLD may present as a schizophrenia-like psychosis, deterioration of cognitive functions, personality changes, depression and dementia. However, there are individuals with low ASA activity without clinical symptoms of MLD...

...Georg Adler; Anke Bramesfeld; Ana Jajcevic Reversible dementia in geriatric depression is known to be a risk factor for irreversible dementia. Whether just mild cognitive deficits in elderly depressed patients hold a similar risk is not known yet. It may be suggested that elderly depressed patients...